Novo A/S, the parent company of Novo Nordisk and Novozymes, owns almost half of the British pharmaceutical company, Archimedes Pharma, after making a multi-million dollar investment in the company.

This entry was posted on Monday, March 8th, 2010 at 8:11 am by David Hoskin and is filed under Business, Global Denmark. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.